Prospective Cohort Study of Complications and Outcomes in Cirrhosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prospective Cohort Study of Complications and Outcomes in Cirrhosis — Stella

Recruiting

Back to Decompensated Cirrhosis trials

Trial locations(1 site)

China

Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong

Key details

Sponsor

Nanfang Hospital, Southern Medical University

Enrollment target

~660 participants

Started

January 2024

Primary completion

April 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov